These soluble factors like IL-6, IL-10, IDO, M-CSF, TGF-β1, PGE2, VEGF present in TME reprogram DCs to possess inefficient antigen-presenting capabilities, and an immunosuppressive regulatory phenotype that supports tumor progression [139–143]. The gene discussed is TGFB1; the disease is neoplasm.